Bayer (BAYN.DE) Stock Price

Currency:

Bayer Price

🇩🇪XETRA·CLOSED

41.84EUR

Market closed

Today +/-

+0.08 EUR

Today %

+0.19 %

PRO

Bayer (BAYN.DE) — ISIN DE000BAY0017. The Bayer stock price was 41.84 EUR in 2026. Revenue was 46.76 B EUR. Earnings were 4.8 B EUR. P/E ratio was 8.56. Bayer operates in the Health sector.

Bayer stock price

Ex-Dividend

Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Bayer over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Bayer stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Bayer's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Bayer Stock Price History

Date	Bayer Price
2/27/2026	41.84 EUR
2/26/2026	41.76 EUR
2/25/2026	42.59 EUR
2/23/2026	43.05 EUR
2/20/2026	44.97 EUR
2/19/2026	45.58 EUR
2/18/2026	45.45 EUR
2/17/2026	49.32 EUR
2/16/2026	45.94 EUR
2/13/2026	45.99 EUR
2/12/2026	45.69 EUR
2/11/2026	46.13 EUR
2/10/2026	46.17 EUR
2/9/2026	46.28 EUR
2/6/2026	45.80 EUR
2/5/2026	44.82 EUR
2/4/2026	45.15 EUR
2/3/2026	45.27 EUR

API Docs Get API Key

Bayer Revenue, EBIT, Net Income

3 Years
5 Years
10 Years
25 Years
Max

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

Revenue

EBIT

Net Income

Details

API Docs Get API Key

Bayer Income Statement, Balance Sheet, Cash Flow Statement

Last updated Mar 4, 2026, 8:39 AM

REVENUE (B EUR)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (B EUR)

NET INCOME (B EUR)

NET INCOME GROWTH (%)

DIVIDEND (EUR)DIV. (EUR)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (M)

DOCUMENTS

1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e	2028e	2029e	2030e	2031e
20.97	22.2	22.79	24.85	28.12	28.06	25.19	29.99	28.94	28.96	28.57	29.76	27.38	28.96	32.39	32.92	31.17	35.09	36.53	39.76	40.16	41.34	46.09	34.94	35.02	36.74	43.55	41.4	44.08	50.74	47.64	46.61	46.53	46.76	47.83	50.06	51.25	51.32	50.2
–	5.88	2.67	9.04	13.16	-0.22	-10.22	19.02	-3.49	0.07	-1.35	4.17	-7.98	5.74	11.84	1.65	-5.32	12.58	4.10	8.85	1.00	2.94	11.48	-24.18	0.21	4.93	18.52	-4.93	6.48	15.10	-6.11	-2.16	-0.17	0.50	2.29	4.65	2.40	0.12	-2.17
42.04	43.28	42.55	42.29	42.93	44.85	46.08	46.81	42.84	39.54	41.07	41.59	45.12	47.25	49.51	50.01	51.44	51.26	50.79	52.06	51.82	51.84	54.35	66.36	67.49	58.14	59.55	53.77	61.85	60.84	58.54	54.36	54.46	54.19	52.97	50.62	49.43	49.37	50.47
8.82	9.61	9.7	10.51	12.07	12.59	11.61	14.04	12.4	11.45	11.73	12.38	12.36	13.68	16.03	16.46	16.03	17.99	18.55	20.7	20.81	21.43	25.05	23.19	23.63	21.36	25.93	22.26	27.27	30.87	27.89	25.34	25.34	25.34	25.34	25.34	25.34	25.34	25.34
0.68	1.01	1.22	1.39	1.5	1.61	2	1.82	0.97	1.06	-1.36	0.6	1.6	1.68	4.71	1.72	1.36	1.3	2.47	2.45	3.19	3.43	4.11	4.53	7.34	1.7	4.09	-10.5	1	4.15	-2.94	-2.55	4.71	4.8	5.23	5.8	6.13	6.28	0
–	48.53	21.55	13.81	7.97	7.31	24.04	-9.29	-46.86	9.84	-228.40	-144.31	164.84	5.39	179.92	-63.51	-20.94	-4.27	89.85	-0.97	30.38	7.43	19.96	10.24	61.91	-76.89	141.36	-356.54	-109.53	315.00	-170.87	-13.23	-284.64	1.85	8.92	10.96	5.71	2.35	–
-	-	-	-	-	-	-	-	-	-	-	-	0.55	0.95	1.00	1.35	1.40	1.40	1.50	1.65	1.90	2.10	2.25	2.50	2.70	2.80	2.80	2.80	2.00	2.00	2.40	0.11	0.11	5.02	5.46	-	-	-	-
–	–	–	–	–	–	–	–	–	–	–	–	–	72.73	5.26	35.00	3.70	–	7.14	10.00	15.15	10.53	7.14	11.11	8.00	3.70	–	–	-28.57	–	20.00	-95.42	–	4,463.64	8.76	–	–	–	–
381	393	736	727	742	742	742	742	742	742	742	742	742	805	837	838	839	840	840	840	840	840.31	840.31	845.95	885.19	940.76	981.69	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Bayer generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Bayer retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Bayer's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Bayer has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Bayer's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

ASSETS

CASH BALANCE (B EUR)

RECEIVABLES (B EUR)

OTHER RECEIVABLES (B EUR)OTHER REC. (B EUR)

INVENTORIES (B EUR)

OTHER CURRENT ASSETS (B EUR)OTHER CURRENT LIAB. (B EUR)

CURRENT ASSETS (B EUR)

TANGIBLE ASSETS (B EUR)

LONG-TERM INVESTMENTS (B EUR)LONG-T. INVEST. (B EUR)

LONG-TERM RECEIVABLES (B EUR)LONG-T. REC. (B EUR)

INTANGIBLE ASSETS (B EUR)INTANGIBLE ASSETS (B EUR)

GOODWILL (B EUR)

OTHER NON-CURRENT ASSETS (B EUR)OTHER NON-CURRENT ASSETS (B EUR)

NON-CURRENT ASSETS (B EUR)

TOTAL ASSETS (B EUR)

LIABILITIES

COMMON STOCK (B EUR)

ADDITIONAL PAID-IN CAPITAL (B EUR)

RETAINED EARNINGS (B EUR)

OTHER EQUITY (B EUR)OTHER EQUITY (B EUR)

UNREALIZED GAINS/LOSSES (M EUR)UNREAL. GAINS/LOSSES (M EUR)

EQUITY (B EUR)

LIABILITIES (B EUR)

PROVISIONS (B EUR)

OTHER SHORT-TERM LIABILITIES (B EUR)OTHER SHORT-TERM LIAB. (B EUR)

SHORT-TERM DEBTS (B EUR)SHORT-TERM DEBTS (B EUR)

SHORT-TERM PORTION OF LONG-TERM DEBTS (B EUR)LONG-TERM DEBT PORTION (B EUR)

SHORT-TERM RECEIVABLES (B EUR)SHORT-TERM REC. (B EUR)

LONG-TERM LIABILITIES (B EUR)LONG-T. LIAB. (B EUR)

DEFERRED TAXES (B EUR)

OTHER LIABILITIES (B EUR)OTHER LIAB. (B EUR)

LONG-TERM LIABILITIES (B EUR)LONG-T. LIABILITIES (B EUR)

DEBT (B EUR)

TOTAL CAPITAL (B EUR)

1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

2.68	2.96	2.66	2.42	2.46	1.72	3.14	0.7	0.77	0.8	2.86	3.6	3.74	3.32	2.87	2.3	2.85	3.55	4.29	2.12	1.8	2.06	2.13	5.42	9.1	5	5.4	11.88	7.74	10.15	10.59	8.09
4.32	4.4	4.35	4.92	5.46	5.57	5.33	6.24	5.42	5.54	5.07	5.58	5.2	5.8	5.83	5.95	6.11	6.67	7.06	7.43	7.57	9.1	9.93	10.97	8.58	11.71	11.68	9.55	10.05	10.31	9.34	8.97
0.89	1.11	1.19	1.49	1.44	1.66	1.58	2.41	2.45	4.21	3.85	4.15	2.15	1.8	1.67	1.79	1.7	1.5	1.79	1.85	1.72	1.29	1.46	3.77	2.45	2.42	3.17	2.61	2.93	3.14	3.18	3.22
4.18	4.26	4.76	5.14	5.42	5.78	4.99	6.1	5.82	6.34	5.89	6.22	5.5	6.15	6.22	6.68	6.09	6.1	6.37	6.98	7.13	8.48	8.55	8.41	6.55	11.13	10.65	10.96	11.31	13.64	13.95	13.47
0	0.21	0.09	0	0	0	0	0	0	0	0	0	0	2.93	0.08	0.44	0.24	0.5	0.56	0.61	0.81	0.63	1.75	1.88	3.39	0.79	1.53	0.67	0.55	0.82	0.8	0.7
12.07	12.93	13.04	13.97	14.78	14.74	15.04	15.46	14.45	16.89	17.67	19.55	16.59	19.99	16.67	17.16	16.99	18.32	20.07	18.99	19.03	21.55	23.82	30.45	30.07	31.07	32.44	35.68	32.58	38.06	37.85	34.44
7.51	7.55	7.97	8.98	10.31	10.83	11.99	13.35	13.54	12.44	9.94	9.18	8.32	8.87	8.82	9.49	9.41	9.84	9.82	9.86	10.02	11.43	12.38	13.11	7.63	12.94	12.48	11.72	12.69	13.67	13.32	13.46
0.59	0.63	0.98	0.99	0.87	1.1	1.42	2.16	3.15	2.2	1.78	1.65	2.22	1.63	1.61	1.36	1.22	1.28	1.4	1.36	0.46	1.19	1.22	1.75	5.27	1.59	0.97	0.99	1.2	1.49	1.34	1.35
0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.17	0.67	0.46	0.55	0.53	0.46	0.55	1.22	0.32	0.33	0.41	0.48	1.5	1.5	1.51	2.01	1.9	2.19	1.95
0.16	0.39	0.45	0.46	0.54	0.7	1.51	3.87	4.04	6.02	4.58	4.14	5.07	15.81	14.56	13.95	12.84	11.16	10.3	9.46	8.91	15.65	15.18	13.57	11.67	36.7	34.71	25.42	26.26	24.18	23.36	22.11
0	0	0.03	0.27	0.51	1.21	0.71	0.98	0.98	2.86	1.94	1.88	2.62	8.23	8.22	8.65	8.7	9	9.16	9.29	9.86	15.35	16.1	16.31	14.75	38.44	39.13	36.42	40.11	39.65	32.3	30.02
0.22	0.17	0.17	0.62	0.68	0.68	0.62	0.65	0.89	1.29	1.54	1.4	1.7	1.21	0.85	1.44	1.33	1.38	1.56	1.82	1.82	4.08	4.89	6.64	5.21	4.5	4.95	5.07	5.41	6.22	6.19	7.52
8.47	8.74	9.61	11.31	12.91	14.52	16.24	20.99	22.59	24.8	19.77	18.26	20.13	35.9	34.71	35.35	34.05	33.19	32.7	32.35	32.29	48.01	50.1	51.79	45.01	95.67	93.74	81.13	87.66	87.12	78.7	76.41
20.54	21.66	22.65	25.28	27.7	29.25	31.28	36.45	37.04	41.69	37.45	37.8	36.72	55.89	51.38	52.51	51.04	51.51	52.77	51.34	51.32	69.56	73.92	82.24	75.09	126.73	126.17	116.8	120.24	125.17	116.56	110.85

1.72	1.77	1.8	1.85	1.87	1.87	1.87	1.87	1.87	1.87	1.87	1.87	1.87	1.96	1.96	1.96	2.12	2.12	2.12	2.12	2.12	2.12	2.12	2.12	2.12	2.39	2.52	2.52	2.52	2.52	2.52	2.52
2.39	2.51	2.59	2.86	2.95	2.95	2.94	2.94	2.94	2.94	2.94	2.94	2.94	4.03	4.03	4.03	6.17	6.17	6.17	6.17	6.17	6.17	6.17	9.66	9.66	18.39	18.26	18.26	18.26	18.26	18.26	18.26
5.32	5.16	5.94	6.8	7.78	8.73	9.97	10.86	10.81	11.14	9.12	9.36	6.94	8.22	12.95	13.01	10.61	10.55	10.93	10.19	12.43	11.82	15.98	18.56	25.03	25.74	26.15	13.06	13.35	17.23	12.18	9.87
-0.34	-0.95	-1.22	-0.98	-0.58	-0.98	0.23	0.47	1.3	-0.61	-1.72	-1.97	-0.74	-1.5	-2.29	-2.8	0	0	0	0	0	0	0	0	0	-0.66	0.02	-3.43	-1.31	0.65	-0.11	1.25
0	0	0	0	0	0	0	0	0	0	0	66	62	58	86	68	0	0	0	0	0	0	0	0	0	122	310	117	212	112	81	16
9.09	8.49	9.11	10.53	12.01	12.57	15.01	16.14	16.92	15.34	12.21	12.27	11.08	12.77	16.73	16.26	18.9	18.83	19.21	18.47	20.72	20.11	24.27	30.33	36.8	45.98	47.25	30.52	33.02	38.77	32.93	31.91
1.07	1.23	1.24	1.33	1.6	1.61	1.56	2.02	1.99	2.53	2.27	2.28	1.97	2.37	2.47	2.46	2.74	3.5	3.78	4.3	4.47	5.36	5.95	6.41	5.13	6.04	6.43	5.68	6.79	7.55	7.46	7.52
0.44	0.49	0.46	0.47	0.48	0.53	0.6	0.58	0.59	0.81	0.73	0.69	0	0	0	0.85	0.84	0.78	0.82	0.78	0.78	0.78	0.98	1.08	0.16	0.37	0.34	0.37	0.34	0.43	0.35	0.98
1.01	1.88	1.93	2.17	1.37	1.41	2.64	4.18	3.85	3.78	4.6	5.09	5.92	8.67	7.04	4.71	4.18	5.1	5.56	5.82	6.61	7.75	7.58	8.15	7.25	13.76	14.47	22.36	19.22	19.57	16.94	15.25
0.07	0.05	0.04	0.05	0.85	0.93	0.33	1.83	1.47	1.18	0.93	1	0.18	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.21	1.08	1.04	1.13	0.85	1.34	1.69	1.25	1.71	1.47	0.86	0.84	1	4.48	1.11	5.81	1.23	1.46	3.24	2.21	2.16	1.44	2.47	2.89	1.05	2.96	1.98	8.36	3.05	7.54	4.7	5.21
3.79	4.73	4.69	5.15	5.15	5.83	6.81	9.85	9.61	9.77	9.39	9.89	9.07	15.52	10.61	13.84	8.97	10.84	13.39	13.1	14.02	15.34	16.98	18.54	13.59	23.13	23.22	36.77	29.4	35.08	29.46	28.95
1.32	1.26	1.44	1.62	2.15	2.29	2.36	2.8	3.07	7.32	7.11	7.12	7.19	14.72	12.91	9.96	10.95	9.64	7.75	6.76	5.4	17.8	16.33	15.38	12.16	37.71	36.91	33.2	36.48	33.78	38.17	35.49
0	0	0	0.43	0.62	0.78	1.16	1.6	1.24	2.45	1.46	1.25	0.28	4.35	3.87	3.59	3.21	2.58	2.12	0.94	1.19	0.69	0.83	1.33	1.15	4.67	3.76	1.18	0.93	0.73	0.79	0.87
6.12	6.95	7.16	7.32	7.55	7.58	5.77	5.82	6.1	6.7	7.15	7.17	9.03	8.46	7.17	8.78	8.96	9.55	10.24	11.97	9.9	16.03	14.33	15.1	11.32	15.08	14.86	14.99	20.26	16.36	14.76	13.5
7.44	8.21	8.6	9.37	10.31	10.65	9.29	10.22	10.41	16.47	15.72	15.54	16.5	27.53	23.95	22.34	23.12	21.78	20.1	19.67	16.49	34.51	31.49	31.8	24.63	57.46	55.53	49.36	57.67	50.87	53.72	49.85
11.23	12.94	13.29	14.52	15.46	16.48	16.1	20.07	20.02	26.24	25.11	25.43	25.57	43.04	34.56	36.17	32.09	32.61	33.49	32.77	30.51	49.85	48.47	50.34	38.23	80.58	78.74	86.13	87.07	85.95	83.18	78.81
20.32	21.43	22.4	25.05	27.47	29.04	31.1	36.21	36.94	41.57	37.32	37.69	36.64	55.81	51.29	52.43	50.99	51.44	52.71	51.24	51.23	69.95	72.74	80.67	75.03	126.56	125.99	116.65	120.09	124.72	116.11	110.71

Details

Balance Sheet

ⓘ

What Is the Balance Sheet?

The balance sheet is a financial snapshot of Bayer at a specific point in time. It follows the fundamental equation: Assets = Liabilities + Shareholders' Equity. Unlike the income statement (which covers a period), the balance sheet tells you what the company owns, what it owes, and what belongs to shareholders at a given date.

Assets

Current assets (cash, receivables, inventory) can be converted to cash within 12 months and indicate short-term liquidity. Non-current assets (property, equipment, intangible assets, goodwill) represent long-term investments. A high proportion of cash and short-term investments gives Bayer financial flexibility to weather downturns, fund acquisitions, or return capital to shareholders.

Liabilities

Current liabilities (accounts payable, short-term debt) are obligations due within one year. Non-current liabilities (long-term debt, pension obligations) are due further out. Key ratio to watch: the debt-to-equity ratio (Total Debt ÷ Shareholders' Equity). A ratio below 1.0 is generally healthy, meaning the company is funded more by equity than debt. Highly leveraged companies amplify both gains and losses.

Shareholders' Equity

Equity is the residual value belonging to shareholders after all debts are paid. It includes retained earnings (accumulated profits not paid out as dividends) and paid-in capital. Rising equity year over year is a positive sign — it means Bayer is building book value. Declining equity, especially when driven by losses or heavy share buybacks funded by debt, warrants closer scrutiny.

Key Ratios to Derive

From the balance sheet, you can calculate the current ratio (current assets ÷ current liabilities; above 1.5 is comfortable), book value per share (equity ÷ shares outstanding), and return on equity (net income ÷ equity; above 15 % is strong). Tracking these ratios over time reveals whether Bayer is strengthening or weakening its financial position.

NET INCOME (B EUR)

DEPRECIATION AND AMORTIZATION B EURDEPRECIATION (B EUR)

DEFERRED TAXES (M EUR)

CHANGES IN WORKING CAPITAL (B EUR)CHANGES IN WORKING CAPITAL (B EUR)

NON-CASH ITEM (B EUR)

PAID INTEREST (B EUR)

PAID TAXES (B EUR)

Net Cash Flow from Operating Activities (B EUR)NET CASH FLOW FROM OPERATING ACTIVITIES (B EUR)

CAPITAL EXPENDITURES (M EUR)

CASH FLOW FROM INVESTING ACTIVITIES (B EUR)CASH FLOW FROM INVESTING ACTIVITIES (B EUR)

CASH FLOW FROM OTHER INVESTING ACTIVITIES (B EUR)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B EUR)

INTEREST INCOME AND EXPENSES (M EUR)

NET DEBT CHANGE (B EUR)NET DEBT CHANGE (B EUR)

Net change in equity (B EUR)NET CHANGE IN EQUITY (B EUR)

CASH FLOW FROM FINANCING ACTIVITIES (B EUR)CASH FLOW FROM FINANCING ACTIVITIES (B EUR)

OTHER ITEMS OF FINANCING CASH FLOWS (EUR)CASH FLOW FROM OTHER FINANCING ACTIVITIES (EUR)

TOTAL DIVIDENDS PAID (M EUR)

NET CHANGE IN CASH FLOW (B EUR)

FREE CASH FLOW (M EUR)

SHARE-BASED COMPENSATION (M EUR)

1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
1.2	1.66	2.1	2.31	2.78	3.15	3.36	3.29	1.61	1.57	-1.2	1.81	2.81	1.53	2.31	1.72	1.36	1.31	2.47	2.5	3.19	3.44	4.02	4.56	3.25	1.39	2.43	-15.56	1.02	4.17	-2.94	-2.55
1.37	1.24	1.18	1.31	1.56	1.53	1.81	2.14	2.52	3.31	4.74	2.32	1.84	1.91	2.71	2.72	2.81	3.56	2.77	2.96	2.9	2.94	3.33	3.74	2.66	6.24	5.37	13.26	3.06	6.5	10.02	8.78
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.39	-0.28	-1.58	-1.43	-0.86	-1.42	-0.77	-1.95	0.3	1.07	-0.56	-1.29	-0.48	-0.29	-1.49	-1.86	0.59	0.52	-0.29	-0.88	-1.28	-1.24	-1.18	-0.87	-0.26	2.87	-0.51	6	0.26	-4.09	-3.86	-0.43
0.4	0.29	0.29	0.14	0.02	-0.46	-1.27	-0.36	-0.53	-1.53	0.32	-0.39	-0.87	1.06	3.59	2.54	2.24	1.47	0.84	1.96	3.3	0.89	0.97	1.74	2.68	-2.3	1.14	1.34	1.27	0.88	2	1.87
0.26	0.23	0.27	0.34	0.36	0.34	0.36	0.34	0.51	0.7	0.78	0.72	0.79	1.16	1.34	1.27	1.21	0.92	0.9	0.79	0.55	0.54	0.81	0.85	0.8	1.33	1.52	1.3	1.23	1.3	1.54	1.98
0	0	0	0	0	0	0	0	0	0	0	0	0	0.76	0.92	0.81	0.64	0.9	1.07	1.56	1.64	1.32	2.26	2.09	1.82	2.03	2.56	1.06	2.16	2.03	1.77	1.22
2.59	2.91	1.99	2.32	3.49	2.8	3.13	3.12	3.9	4.42	3.29	2.46	3.31	4.2	4.28	3.61	5.38	5.77	5.06	4.53	5.17	5.81	6.9	9.09	8.13	7.92	8.19	4.9	5.13	7.1	5.12	7.37
-1,613	-1,802	-1,620	-1,933	-2,359	-2,675	-2,632	-2,647	-2,617	-2,239	-1,653	-1,251	-1,389	-1,876	-1,860	-1,759	-1,575	-1,514	-1,615	-1,929	-2,157	-2,371	-2,517	-2,578	-2,366	-2,593	-2,650	-2,418	-2,611	-2,949	-2,751	-2,778
-1.82	-3.21	-2.18	-1.38	-2.41	-3.18	0.21	-6.22	-2.13	-6.57	0.46	-0.81	-1.74	-14.73	3.19	-3.09	-1.13	-2.41	-3.89	-0.82	-2.58	-15.54	-2.76	-8.73	-0.43	-34.15	-0.67	-4.07	0.86	-2.38	-3.52	0.16
-0.21	-1.41	-0.56	0.56	-0.05	-0.51	2.85	-3.58	0.49	-4.33	2.11	0.44	-0.35	-12.85	5.05	-1.33	0.45	-0.9	-2.28	1.11	-0.42	-13.17	-0.25	-6.15	1.93	-31.56	1.98	-1.66	3.47	0.57	-0.77	2.94
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.04	0.52	0.15	0.05	-0.05	0.87	-0.61	2.06	-0.04	3.54	-0.32	0.51	-0.65	10.72	-5.61	1.53	-1.44	-1.54	-0.4	-1.95	-0.62	11.84	-2.93	-0.73	-2.48	17.82	-4.3	4.47	-2.45	-0.97	3.25	-5.02
0.1	0.18	0.11	0.33	0.12	0	0.01	0	0	0	0	0.01	0	1.17	0	0	0	0	0	0	0	0	1.49	3.3	3.72	8.99	0	0	0	-0.01	-0	-0.02
-0.49	0.09	-0.47	-0.5	-0.92	-0.18	-1.73	0.77	-1.55	2.21	-1.76	-0.76	-1.88	10.2	-7.73	-0.87	-3.62	-3.23	-2.21	-3.78	-2.54	9.74	-3.97	-0.35	-1.88	23.43	-8.39	0.42	-5.65	-4.22	-0.68	-7.18
-262.00	-226.00	-271.00	-335.00	-357.00	-344.00	-360.00	-336.00	-484.00	-666.00	-782.00	-724.00	-787.00	-1,155.00	-1,344.00	-1,272.00	-1,206.00	-526.00	-574.00	-471.00	-342.00	-363.00	-666.00	-794.00	-755.00	-966.00	-1,478.00	-1,276.00	-1,200.00	-1,251.00	-1,552.00	-2,013.00
-369	-382	-463	-543	-634	-712	-770	-953	-1,028	-662	-664	-559	-440	-535	-773	-1,126	-973	-1,160	-1,242	-1,366	-1,574	-1,739	-1,869	-2,126	-2,364	-2,407	-2,615	-2,768	-1,993	-1,985	-2,379	-131
0.28	-0.22	-0.33	0.44	0.19	-0.56	1.63	-2.32	0.23	0.05	1.97	0.84	-0.28	-0.38	-0.38	-0.44	0.63	0.12	-1.07	-0.08	-0.04	0.19	0.01	0.04	5.68	-3.38	-0.87	1.01	0.37	0.61	0.74	0.28
973.5	1,103.4	365	390.6	1,132.5	126.8	497	476	1,284	2,185	1,641	1,205	1,917	2,325	2,419	1,852	3,803	4,259	3,445	2,603	3,014	3,439	4,378	6,514	5,768	5,325	5,537	2,478	2,517	4,147	2,366	4,588
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

API Docs Get API Key

Bayer Stock Quarterly Figures

REVENUE (B EUR)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (B EUR)

NET INCOME (B EUR)

NET INCOME GROWTH (%)

DIVIDEND (EUR)DIV. (EUR)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (M)

1999 Q1	1999 Q2	1999 Q3	1999 Q4	2000 Q1	2000 Q2	2000 Q3	2000 Q4	2001 Q1	2001 Q2	2001 Q3	2001 Q4	2002 Q1	2002 Q2	2002 Q3	2002 Q4	2003 Q1	2003 Q2	2003 Q3	2003 Q4	2004 Q1	2004 Q2	2004 Q3	2004 Q4	2005 Q1	2005 Q2	2005 Q3	2005 Q4	2006 Q1	2006 Q2	2006 Q3	2006 Q4	2007 Q1	2007 Q2	2007 Q3	2007 Q4	2008 Q1	2008 Q2	2008 Q3	2008 Q4	2009 Q1	2009 Q2	2009 Q3	2009 Q4	2010 Q1	2010 Q2	2010 Q3	2010 Q4	2011 Q1	2011 Q2	2011 Q3	2011 Q4	2012 Q1	2012 Q2	2012 Q3	2012 Q4	2013 Q1	2013 Q2	2013 Q3	2013 Q4	2014 Q1	2014 Q2	2014 Q3	2014 Q4	2015 Q1	2015 Q2	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4e	2026 Q1e	2026 Q2e	2026 Q3e
5.89	6.2	6.06	6.5	6.96	7.54	7.3	8.19	7.5	7.79	6.71	7.16	7.01	7.27	7.25	7.43	7.36	7.26	6.83	7.12	5.79	5.89	5.49	6.11	6.39	6.69	6.18	5.45	6.79	6.74	7.46	7.97	8.34	8.22	7.79	8.04	8.54	8.51	7.95	7.92	7.9	8.01	7.39	7.87	8.32	9.18	8.58	9.01	9.42	9.25	8.67	9.19	10.05	10.17	9.66	9.86	10.27	10.36	9.64	9.89	10.35	10.23	9.97	10.79	11.79	12	11	11.29	11.85	6.01	8.26	8.82	9.68	8.71	8.03	8.6	9.14	9.48	9.26	10.36	12.25	10.71	9.83	10.75	12.85	10.05	8.51	10	12.33	10.85	9.78	11.12	14.64	12.82	11.28	12	14.39	11.04	10.34	11.86	13.77	11.14	9.97	11.73	13.74	10.74	9.66	11.36	13.77	11.14	10.18
–	5.23	-2.29	7.28	7.14	8.26	-3.12	12.09	-8.33	3.83	-13.81	6.69	-2.14	3.72	-0.30	2.47	-0.97	-1.36	-5.82	4.20	-18.66	1.69	-6.88	11.41	4.50	4.70	-7.61	-11.74	24.56	-0.81	10.73	6.85	4.58	-1.42	-5.16	3.17	6.17	-0.29	-6.61	-0.31	-0.35	1.44	-7.70	6.49	5.64	10.38	-6.51	5.02	4.47	-1.73	-6.29	6.01	9.39	1.11	-4.97	2.06	4.12	0.92	-6.92	2.54	4.69	-1.20	-2.55	8.28	9.28	1.78	-8.32	2.55	5.04	-49.32	37.45	6.84	9.71	-9.98	-7.91	7.12	6.31	3.75	-2.32	11.81	18.32	-12.56	-8.24	9.36	19.49	-21.73	-15.40	17.51	23.34	-11.96	-9.89	13.67	31.67	-12.43	-12.00	6.37	19.91	-23.25	-6.36	14.70	16.04	-19.04	-10.55	17.67	17.13	-21.83	-10.05	17.59	21.19	-19.07	-8.63
48.11	46.70	46.69	45.31	48.85	47.03	46.41	45.23	47.66	43.61	37.73	40.72	42.30	40.05	38.94	37.01	46.02	42.90	38.67	36.86	51.54	45.64	45.76	43.76	46.63	45.53	43.65	47.16	49.37	46.99	46.72	46.15	50.40	50.44	48.95	48.16	51.93	49.99	48.72	49.25	52.05	52.63	51.58	49.49	51.86	51.43	51.45	50.33	52.87	51.17	50.66	48.41	52.71	52.38	51.44	51.49	53.02	52.14	51.77	48.58	54.27	51.20	51.25	50.66	53.90	56.12	55.11	52.18	57.45	85.89	67.11	64.32	69.14	68.06	68.04	64.55	68.17	63.01	55.72	45.49	60.28	62.26	61.52	54.23	63.75	60.04	20.12	63.29	61.89	58.12	60.26	66.86	64.64	55.69	62.35	60.27	60.16	57.28	53.47	62.18	60.31	55.19	48.94	51.21	59.06	59.36	55.41	47.13	38.89	48.05	52.58
2.83	2.9	2.83	2.94	3.4	3.55	3.39	3.7	3.58	3.4	2.53	2.92	2.97	2.91	2.82	2.75	3.39	3.11	2.64	2.63	2.99	2.69	2.51	2.67	2.98	3.04	2.7	2.57	3.35	3.17	3.49	3.68	4.2	4.15	3.82	3.87	4.43	4.26	3.87	3.9	4.11	4.22	3.81	3.9	4.31	4.72	4.42	4.54	4.98	4.73	4.39	4.45	5.3	5.33	4.97	5.08	5.44	5.4	4.99	4.8	5.62	5.24	5.11	5.47	6.36	6.74	6.06	5.89	6.81	5.16	5.54	5.68	6.69	5.93	5.46	5.55	6.23	5.97	5.16	4.71	7.39	6.67	6.05	5.83	8.19	6.04	1.71	6.33	7.63	6.31	5.89	7.43	9.46	7.14	7.03	7.23	8.66	6.33	5.53	7.38	8.3	6.15	4.88	6.01	8.11	6.38	5.35	5.35	5.35	5.35	5.35
0.44	1.28	0.43	-0.15	0.56	0.48	0.53	0.25	0.44	0.56	-0.18	0.14	0.52	0.29	0.66	-0.41	0.59	0.13	-0.12	-1.95	0.42	0.15	0.05	0.07	0.65	0.41	0.49	0.05	0.6	0.45	0.32	0.31	2.81	0.66	1.18	0.07	0.76	0.57	0.28	0.11	0.43	0.53	0.25	0.15	0.63	0.53	0.29	-0.15	0.68	0.75	0.64	0.4	1.04	0.48	0.52	0.37	1.16	0.84	0.73	0.46	1.42	0.95	0.83	0.22	1.33	1.16	1	0.61	1.51	1.38	1.19	0.45	2.08	1.22	3.88	0.15	1.95	0.79	2.87	-3.92	1.24	0.4	1.04	1.41	1.49	-9.55	-2.74	0.31	2.09	-2.34	0.09	1.16	3.29	-0.3	0.55	0.61	2.18	-1.89	-4.57	1.34	2	-0.03	-4.18	-0.34	1.3	-0.2	-0.96	0.47	2.13	0.69	0.37
–	190.68	-66.30	-134.34	-475.68	-14.21	11.95	-53.37	77.51	27.60	-132.45	-177.60	268.31	-43.98	123.89	-162.80	-242.23	-78.16	-196.09	1,486.99	-121.47	-65.16	-64.38	30.77	858.82	-37.73	21.43	-90.67	1,204.35	-24.67	-29.20	-2.81	803.22	-76.50	78.03	-94.30	1,037.31	-24.67	-51.74	-61.73	300.94	25.18	-53.20	-38.55	312.42	-16.01	-46.23	-150.88	-571.72	9.21	-14.06	-38.16	161.96	-53.75	7.28	-29.07	216.94	-27.50	-12.84	-37.93	212.75	-33.03	-13.33	-72.88	495.54	-12.74	-14.18	-38.64	146.49	-8.67	-13.99	-61.84	359.82	-41.24	217.08	-96.19	1,220.27	-59.37	261.59	-236.68	-131.63	-67.45	156.44	36.49	5.30	-741.24	-71.26	-111.22	578.25	-211.78	-103.64	1,265.88	183.46	-109.05	-283.22	11.90	256.46	-186.64	142.13	-129.26	49.59	-101.70	12,202.94	-91.99	-487.76	-115.32	383.92	-149.22	349.37	-67.56	-46.45
2.00	-	-	-	1.30	-	-	1.40	-	-	-	-	0.90	-	-	-	0.90	-	-	-	0.50	-	-	-	0.55	-	-	-	0.95	-	-	-	1.00	-	-	-	1.35	-	-	-	1.40	-	-	-	1.38	-	-	-	1.48	-	-	-	1.62	-	-	-	1.87	-	-	-	2.07	-	-	-	2.21	-	-	-	2.46	-	-	-	2.66	-	-	-	2.76	-	-	-	2.80	-	-	-	2.80	-	-	-	2.00	-	-	-	2.00	-	-	-	2.40	-	-	-	0.11	-	-	-	0.11	-	-	-	-	-	-
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
742	742	742	742	742	742	743	741	742	742	744	740	742	742	742	742	742	742	742	742	742	742	742	742	742	742	742	742	742	742	773	961	837	837	777	958	837	838	838	838	838	839	840	841	840	840	840	840	840	840	840	840	840	840	840	840	840	840	840	840	840	840	840	840	840	840	840	840	840	850	840	863	885	899	887	887	887	916	980.15	980.61	977.17	981.73	982.43	982.41	979.61	982.42	982.42	982.42	980.75	982.42	982.42	982.42	982.39	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42	982.42

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Gross Margin

EBIT and EBIT Margin

Net Income and Earnings Per Share (EPS)

Shares Outstanding

Analyst Estimates

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

API Docs Get API Key

Bayer stock margins

The Bayer margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bayer. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bayer.

3 Years
5 Years
10 Years
25 Years
Max

Gross margin

EBIT margin

Profit margin

Details

API Docs Get API Key

Bayer Stock Sales Revenue, EBIT, Earnings per Share

The Bayer earnings per share therefore indicates how much revenue Bayer has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

3 Years
5 Years
10 Years
25 Years
Max

Sales per Share

EBIT per share

Earnings per Share

Details

API Docs Get API Key

Bayer business model

Bayer AG is a German company that was founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott in Wuppertal. The company started out as a manufacturer of dyes, but over time it has evolved into a leading global agrochemical, health, and life science company. Bayer's business model is based on the goal of finding innovative solutions to the societal challenges of the future. This includes promoting agriculture and health, as well as sustainability and the preservation of natural resources. Bayer specializes in three business areas: Pharmaceuticals, Consumer Health, and Crop Science. In the Pharmaceuticals division, Bayer develops and markets innovative drugs for a variety of diseases. The company focuses on research and development in key therapy areas such as cardiology, oncology, hematology, neurology, and immunology. Well-known and successful brands from Bayer in the Pharmaceuticals sector include Xarelto, Kogenate, Stivarga, Eylea, and Nexavar. In the Consumer Health division, Bayer develops and distributes products for consumer health and well-being. This includes self-medication products, dietary supplements, contact lens care products, and animal health products. Well-known brands from Bayer Consumer Health include Aspirin, Bepanthen, Berocca, Coppertone, and Advantage. In the Crop Science division, Bayer develops and markets products and solutions for agriculture. This includes crop protection products, seeds, plant breeding, and digital farming. The goal is to help farmers worldwide operate sustainably and productively to meet the growing demand for food. Well-known brands from Bayer Crop Science include Roundup, Decis, Diflubenzuron, and Dekalb. Bayer is known for its innovative power and has made many inventions and discoveries throughout its history. It was one of the first companies to develop synthetic dyes, and in 1897, it was also the first company in Germany to manufacture Aspirin. Since then, Bayer has made numerous groundbreaking discoveries and is now at the forefront of the pharmaceutical and agrochemical industry. Bayer is headquartered in Leverkusen and operates in over 90 countries worldwide. The company employs over 100,000 people and had a turnover of around 41 billion euros in 2020. The company is also committed to reducing its ecological footprint in line with its business goals and strives to improve sustainability in its value chain.

API Docs Get API Key

Bayer SWOT Analysis

Strengths

Bayer AG has a diverse product portfolio, encompassing pharmaceuticals, consumer healthcare, agricultural products, and animal health. This diversification allows the company to generate revenue from multiple sources and reduces reliance on any single sector.

The company has a strong global presence with operations in more than 90 countries. This allows Bayer to tap into different markets and benefit from localized strategies and customer preferences.

Bayer boasts a strong research and development (R&D) capability, investing significantly in innovation. This enables the company to introduce new and improved products, keeping it competitive in the rapidly evolving healthcare and agricultural industries.

Weaknesses

Bayer has faced several legal challenges related to its products, including lawsuits concerning alleged side effects of certain medications. These legal battles have had a negative impact on the company's reputation and financial performance.

The company heavily relies on the pharmaceutical sector for a significant portion of its revenue. This concentration poses a risk as market dynamics, regulatory changes, or patent expirations can significantly impact financial stability.

Bayer's acquisition of Monsanto, a controversial move due to concerns over genetically modified organisms (GMOs) and the potential environmental impact, has also raised questions about the company's sustainability practices and public perception.

Opportunities

Growing demand for healthcare and agricultural products in emerging markets presents an opportunity for Bayer to expand its customer base and revenue streams. This includes addressing the rising healthcare needs of an aging global population.

Advancements in technologies such as precision agriculture, gene editing, and digital health open doors for Bayer to develop innovative solutions, improve productivity, and enhance overall operational efficiency in its various sectors.

Bayer can leverage its established brand and reputation to capitalize on the growing consumer interest in organic and sustainable products. Developing and promoting environmentally friendly solutions can lead to market differentiation and increased market share.

Threats

Intense competition from both established pharmaceutical and agricultural companies, as well as emerging players, poses a threat to Bayer's market position. This includes the potential entry of generic and biosimilar products.

Regulatory requirements and government policies can impact the company's ability to market and sell its products. Changes in regulations related to drug pricing, intellectual property, and environmental safety standards can create challenges for Bayer.

Public scrutiny and consumer activism around controversial products, particularly in the agricultural sector, can harm the company's reputation and result in reduced sales or boycotts.

API Docs Get API Key

Bayer Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

API Docs Get API Key

Bayer historical P/E ratio, EBIT multiple, and P/S ratio

API Docs Get API Key

Bayer annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

API Docs Get API Key

Bayer shares outstanding

The number of shares was Bayer in 2025 — This indicates how many shares 982.42 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

3 Years
5 Years
10 Years
25 Years
Max

Number of stocks

Details

API Docs Get API Key

Bayer stock splits

In Bayer's history, there have been no stock splits.

API Docs Get API Key

Bayer Dividend History

36 years of dividend payments

YearAnnual DividendYoY ChangePayments

20250.11EUR 0.0%1×

Apr 28, 20250.11EUR 0.0%1/1

20240.11EUR↓ 95.4%1×

20232.4EUR↑ 20.0%1×

API Docs Get API Key

Bayer dividend history and estimates

In 2025, Bayer paid a dividend amounting to 0.11 EUR. Dividend means that Bayer distributes a portion of its profits to its owners.

3 Years
5 Years
10 Years
25 Years
Max

Dividend

Dividend (Estimate)

Details

API Docs Get API Key

Bayer dividend payout ratio

In 2025, Bayer had a payout ratio of 88.97%. The payout ratio indicates the percentage of the company's profits that Bayer distributes as dividends.

3 Years
5 Years
10 Years
25 Years
Max

Payout ratio

Details

API Docs Get API Key

Current Bayer forecasts and price targets in March 2026

Δ MOM Price Target	19.13 %
Buy	58.62 % (17)
Hold	34.48 % (10)
Sell	6.90 % (2)
12M Price Target	41.92
Last Price	28.21
Currency	EUR
12M Return Potential	48.63 %
LTM Return	0 %

API Docs Get API Key

Unlock Earnings — PRO

Bayer Earnings Estimates

Date	EPS estimate	Revenue Estimate	Quarterly report
5/14/2024	2.88EUR	14.59 BEUR	2024 Q1
3/5/2024	1.41EUR	12.26 BEUR	2023 Q4
8/2/2023	2.35EUR	14.93 BEUR	2023 Q2
5/11/2023	3.69EUR	0EUR	2023 Q1
2/28/2023	1.41EUR	12.29 BEUR	2022 Q4
11/8/2022	1.18EUR	11.09 BEUR	2022 Q3
8/4/2022	1.91EUR	12.55 BEUR	2022 Q2
5/10/2022	3.04EUR	13.96 BEUR	2022 Q1
3/1/2022	1.05EUR	10.83 BEUR	2021 Q4
11/9/2021	0.89EUR	9.39 BEUR	2021 Q3
8/5/2021	1.56EUR	10.45 BEUR	2021 Q2
5/12/2021	2.47EUR	12.25 BEUR	2021 Q1
2/25/2021	1.29EUR	10.28 BEUR	2020 Q4
11/3/2020	1EUR	9.36 BEUR	2020 Q3
8/4/2020	1.56EUR	10.75 BEUR	2020 Q2
4/27/2020	2.66EUR	12.24 BEUR	2020 Q1
2/27/2020	1.28EUR	10.87 BEUR	2019 Q4
10/30/2019	1.2EUR	9.94 BEUR	2019 Q3
7/26/2019	1.8EUR	11.87 BEUR	2019 Q2
4/25/2019	2.5EUR	12.71 BEUR	2019 Q1
2/27/2019	1.68EUR	10.76 BEUR	2018 Q4
11/13/2018	1.08EUR	10.37 BEUR	2018 Q3
9/5/2018	1.55EUR	9.2 BEUR	2018 Q2
5/3/2018	2.07EUR	9.53 BEUR	2018 Q1
2/28/2018	1.13EUR	8.92 BEUR	2017 Q4
10/26/2017	1.49EUR	9.8 BEUR	2017 Q3
7/27/2017	1.77EUR	12.77 BEUR	2017 Q2
4/27/2017	2.4EUR	13.05 BEUR	2017 Q1
2/22/2017	1.24EUR	11.87 BEUR	2016 Q4
10/26/2016	1.65EUR	11.47 BEUR	2016 Q3
7/27/2016	2.02EUR	12.31 BEUR	2016 Q2
4/26/2016	2.19EUR	12.23 BEUR	2016 Q1
2/25/2016	1.27EUR	11.43 BEUR	2015 Q4
10/29/2015	1.49EUR	11.41 BEUR	2015 Q3
7/29/2015	1.85EUR	12.04 BEUR	2015 Q2
4/30/2015	2.16EUR	12.07 BEUR	2015 Q1
2/26/2015	1.2EUR	10.84 BEUR	2014 Q4
10/30/2014	1.27EUR	10.11 BEUR	2014 Q3
7/30/2014	1.59EUR	10.75 BEUR	2014 Q2
4/28/2014	1.82EUR	10.66 BEUR	2014 Q1
2/28/2014	1.24EUR	10.23 BEUR	2013 Q4
10/31/2013	1.23EUR	9.47 BEUR	2013 Q3
7/31/2013	1.47EUR	10.59 BEUR	2013 Q2
4/25/2013	1.8EUR	10.73 BEUR	2013 Q1
2/28/2013	1.08EUR	9.83 BEUR	2012 Q4
10/30/2012	1.15EUR	9.43 BEUR	2012 Q3
7/31/2012	1.35EUR	9.92 BEUR	2012 Q2
4/26/2012	1.48EUR	9.88 BEUR	2012 Q1
2/28/2012	0.95EUR	9.26 BEUR	2011 Q4
10/27/2011	1.03EUR	8.81 BEUR	2011 Q3
7/28/2011	1.32EUR	9.69 BEUR	2011 Q2
4/28/2011	1.4EUR	9.22 BEUR	2011 Q1
2/28/2011	0.95EUR	8.7 BEUR	2010 Q4
10/28/2010	0.94EUR	8.46 BEUR	2010 Q3
7/29/2010	1.19EUR	8.76 BEUR	2010 Q2
4/29/2010	1.2EUR	8.39 BEUR	2010 Q1
2/26/2010	0.86EUR	7.93 BEUR	2009 Q4
10/27/2009	0.79EUR	7.63 BEUR	2009 Q3
7/29/2009	0.78EUR	7.99 BEUR	2009 Q2
4/29/2009	0.96EUR	8.05 BEUR	2009 Q1
3/3/2009	0.55EUR	7.89 BEUR	2008 Q4
10/29/2008	0.77EUR	7.94 BEUR	2008 Q3
7/30/2008	1.06EUR	8.52 BEUR	2008 Q2
4/24/2008	1.26EUR	8.7 BEUR	2008 Q1
2/28/2008	0.42EUR	8.24 BEUR	2007 Q4
11/6/2007	0.47EUR	7.81 BEUR	2007 Q3
8/7/2007	0.9EUR	8.36 BEUR	2007 Q2
5/8/2007	0.83EUR	8.55 BEUR	2007 Q1
3/15/2007	0.28EUR	8.17 BEUR	2006 Q4
11/27/2006	0.38EUR	8.01 BEUR	2006 Q3
8/29/2006	0.67EUR	7.33 BEUR	2006 Q2
4/27/2006	0.9EUR	7.2 BEUR	2006 Q1
3/6/2006	0.43EUR	6.88 BEUR	2005 Q4
11/9/2005	0.33EUR	6.31 BEUR	2005 Q3
8/11/2005	0.62EUR	0EUR	2005 Q2

...

EESG©

Eulerpool ESG Scorecard© for the Bayer stock

85/100

Environment

Social

Governance

Environment

Scope 1 - Direct Emissions1,880,000

Scope 2 - Indirect emissions from purchased energy1,650,000

Scope 3 - Indirect emissions within the value chain8,380,000

Total CO₂ emissions3,530,000

CO₂ reduction strategy

Coal energy

Nuclear power

Animal experiments

Fur & Leather

Pesticides

Palm Oil

Tobacco

Genetically modified organisms

Climate concept—

Sustainable forestry—

Recycling regulations

Environmentally friendly packaging

Hazardous substances

Fuel consumption and efficiency

Water consumption and efficiency

Social

Percentage of female employees42.1

Percentage of women in management—

Percentage of Asian employees13

Share of Asian management—

Percentage of Hispanic/Latino employees11

Hispano/Latino Management share—

Percentage of Black employees5

Black Management Share—

Percentage of white employees68

White Management Share—

Adult content

Alcohol

Weapons—

Firearms

Gambling

Military contracts

Human rights concept

Privacy concept—

Occupational health and safety

Catholic

Governance (Corporate Governance)

Environmental reporting

Stakeholder Engagement

Call Back Policies

Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

API Docs Get API Key

Bayer shareholders

%	Name	Stocks	Change	Date
7.17652%	BlackRock Institutional Trust Company, N.A.	70,503,573	+4,162,686	7/29/2025
3.46887%	Temasek Holdings Pte. Ltd.	34,078,853		12/31/2024
3.24062%	The Vanguard Group, Inc.	31,836,511	+6,831	7/31/2025
3.00248%	Silchester International Investors, L.L.P.	29,496,952		12/31/2024
2.99392%	Amundi Asset Management, SAS	29,412,861	+1,041,392	5/16/2025
2.93776%	Norges Bank Investment Management (NBIM)	28,861,165		12/31/2024
2.89842%	MFS Investment Management	28,474,699		12/31/2024
2.87385%	Dodge & Cox	28,233,293	+2,523,717	2/13/2025
1.96213%	Harris Associates L.P.	19,276,358	-9,897,566	6/30/2025
1.14187%	BlackRock Advisors (UK) Limited	11,217,982	+288,611	7/31/2025
0.94291%	Geode Capital Management, L.L.C.	9,263,374	+130,925	6/30/2025
0.89969%	BlackRock Asset Management Deutschland AG	8,838,775	-140,847	7/31/2025
0.88304%	Dimensional Fund Advisors, L.P.	8,675,177	+251,866	7/31/2025
0.84147%	DWS Investment GmbH	8,266,800	+141,758	7/31/2025
0.70697%	Fidelity Institutional Asset Management	6,945,418	-31,236	3/31/2025
0.57295%	Charles Schwab Investment Management, Inc.	5,628,797	+16,889	7/31/2025
0.56190%	Fidelity Management & Research Company LLC	5,520,256	+79,028	6/30/2025
0.55673%	Capital World Investors	5,469,429	+11,902	7/31/2025
0.37846%	Goldman Sachs Asset Management, L.P.	3,718,034	+72,617	6/20/2025
0.33662%	Fidelity Investments Canada ULC	3,307,071	+179,197	3/31/2025
0.31579%	BlackRock Investment Management (UK) Ltd.	3,102,432	+3,891	6/30/2025
0.31164%	State Street Global Advisors (US)	3,061,619	+11,274	7/31/2025
0.30911%	Arga Investment Management, LP	3,036,743	-74,666	6/30/2025
0.27794%	Schroder Investment Management Ltd. (SIM)	2,730,523	-13,360	6/30/2025
0.26890%	Lazard Asset Management, L.L.C.	2,641,687	-80,719	7/31/2025
0.25162%	JPMorgan Asset Management U.K. Limited	2,471,947	+1,685,371	6/30/2025
0.24470%	CPP Investment Board	2,404,000	+629,000	3/31/2024
0.24016%	Deka Investment GmbH	2,359,345	+25,228	7/31/2025
0.23951%	California State Teachers Retirement System	2,352,987	+569,552	6/30/2024
0.23883%	State Street Global Advisors (UK) Ltd.	2,346,346	+15,641	7/31/2025
0.23758%	Fidelity International	2,333,989	+395,387	6/30/2025
0.22178%	Cobas Asset Management, SGIIC, SA	2,178,837	-26,518	6/30/2025
0.21007%	Ruffer LLP	2,063,785	-65,160	6/30/2025
0.20572%	Baillie Gifford & Co.	2,021,064	-1,502	3/31/2025
0.20471%	Aviva Investors Global Services Limited	2,011,094	-6,324	6/30/2025
0.19683%	Macquarie Investment Management	1,933,650		5/31/2024
0.17655%	California Public Employees' Retirement System	1,734,507	-71,038	6/30/2024
0.17645%	HSBC Global Asset Management (UK) Limited	1,733,475	+41,609	6/30/2025
0.17411%	JP Morgan Asset Management	1,710,477	+43,756	7/31/2025
0.16422%	Nuveen LLC	1,613,304		6/30/2025
0.15049%	Jupiter Asset Management Ltd.	1,478,424	+1,478,424	6/30/2025
0.14601%	Van Eck Associates Corporation	1,434,408	-21	7/31/2025
0.14486%	UBS Asset Management (UK) Ltd.	1,423,165	+25,339	7/31/2025
0.14169%	CapitalatWork - Foyer Group	1,392,017		6/30/2025
0.13407%	Legal & General Investment Management Ltd.	1,317,109	+878	7/31/2025
0.12087%	Dimensional Fund Advisors, Ltd.	1,187,404	+32,000	6/30/2025
0.10702%	DWS Investments UK Limited	1,051,419	+16,663	7/31/2025
0.10573%	Putnam Investment Management, L.L.C.	1,038,725	+477,050	6/30/2025
0.09832%	azValor Asset Management SGIIC, SAU	965,960	+965,960	12/31/2024
0.09478%	Vanguard Global Advisers LLC	931,161	+8,030	6/30/2025
0.09472%	Union Investment Privatfonds GmbH	930,518		9/30/2024
0.09087%	BNP Paribas Asset Management Europe SAS	892,709	+130,106	6/30/2025
0.08934%	MEAG Munich ERGO Kapitalanlagegesellschaft mbH	877,734	+710,444	3/31/2025
0.08803%	DIVAS Asset Management AG	864,841	-25,626	6/30/2025
0.08491%	Northern Trust Investments, Inc.	834,169	+603	7/31/2025
0.08302%	AQR Capital Management, LLC	815,564	+334,376	6/30/2025
0.07936%	Northern Trust Global Investments Limited	779,605	+132,216	6/30/2025
0.07613%	BlackRock Financial Management, Inc.	747,887	+5,932	2/28/2025
0.07527%	M&G Investment Management Ltd.	739,459	+542,174	4/30/2025
0.07505%	Franklin Advisers, Inc.	737,263	+275,362	6/30/2025
0.06983%	BNP Paribas Asset Management UK Limited	686,070	+24,323	6/30/2025
0.06804%	1832 Asset Management L.P.	668,427	+584,420	12/31/2024
0.06734%	Pacer Advisors, Inc.	661,610	-203,971	6/30/2025
0.06728%	UBS Fund Management (Switzerland) AG	660,971	+11,641	7/31/2025
0.06722%	Vanguard Investments Australia Ltd.	660,427	-1,835	6/30/2025
0.06610%	BlackRock Asset Management Canada Limited	649,399		7/31/2025
0.06260%	Pzena Investment Management, LLC	615,028	-97,194	6/30/2025
0.05766%	Handelsbanken Kapitalförvaltning AB	566,472	+20,347	6/30/2025
0.05443%	Zürcher Kantonalbank (Asset Management)	534,692	+6,869	7/31/2025
0.05289%	American Century Investment Management, Inc.	519,647	+43,497	7/31/2025
0.05012%	DBX Advisors LLC.	492,426		7/31/2025
0.04828%	Oddo BHF Asset Management GmbH	474,345	+6,200	6/30/2025
0.04526%	Niche Asset Management Limited	444,600		5/31/2025
0.04426%	Invesco Capital Management LLC	434,825	-173	7/31/2025
0.04337%	BWM AG	426,100		6/30/2025
0.04258%	Seligson & Co Rahastoyhtiö Oyj	418,341	-734	5/31/2025
0.04129%	Assenagon Asset Management S.A.	405,604	+1,691	7/31/2025
0.03982%	Eurizon Capital SGR S.p.A.	391,220	+117,321	6/30/2025
0.03965%	Mediolanum International Funds Limited	389,550	+57,833	3/31/2025
0.03870%	Lansförsäkringar Fondförvaltning AB	380,201	+4,961	6/30/2025
0.03827%	Ilmarinen Mutual Pension Insurance Company	376,004	+166,816	12/31/2024
0.03576%	Bank Julius Bär & Co. AG	351,348		6/30/2025
0.03558%	UBS Asset Management (Switzerland)	349,561	-2,796	7/31/2025
0.03516%	UBS Asset Management Switzerland AG	345,454		6/30/2025
0.03471%	BMO Asset Management Inc.	340,966	-31,500	7/31/2025
0.03363%	TD Asset Management Inc.	330,346	+2,914	6/30/2025
0.03298%	Rothschild & Co Asset Management Europe SCS	323,982	+323,982	6/30/2025
0.03244%	AllianceBernstein L.P.	318,699	-6,637	6/30/2025
0.03216%	Link Fund Solutions, Ltd.	315,930		6/30/2024
0.03024%	Manulife Investment Management (North America) Limited	297,104		6/30/2025
0.02921%	TOP Vermögensverwaltung AG	287,000		6/30/2025
0.02868%	Pictet Asset Management Ltd.	281,767	+16,229	4/30/2025
0.02859%	T. Rowe Price Associates, Inc.	280,888	+29,832	6/30/2025
0.02834%	PIMCO (US)	278,413		6/30/2025
0.02785%	Anima SGR S.p.A.	273,652	-449	1/31/2025
0.02702%	BlackRock Investment Management, LLC	265,405	-1,481	6/30/2025
0.02466%	Epsilon SGR SpA	242,226		6/30/2025
0.02403%	Neuberger Berman, LLC	236,030	+196	6/30/2025
0.02401%	SK Vermögensverwaltung GmbH	235,900	+10,000	6/30/2025
0.02347%	FPS Vermögensverwaltung GmbH	230,600		12/31/2023

...

API Docs Get API Key

Bayer Executives and Management Board

Mr. William Anderson

(57)

Chairman of the Management Board, Chief Executive Officer

Compensation8.84 MEUR

Compensation8.84 M EUR

Mr. Rodrigo Santos

(50)

Member of the Management Board, Head of the Crop Science

3.77 MEUR

Compensation3.77 M EUR

Mr. Stefan Oelrich

(55)

Member of the Management Board, Head of the Pharmaceuticals Division

3.68 MEUR

Compensation3.68 M EUR

Mr. Wolfgang Nickl

(54)

Chief Financial Officer, Member of the Management Board

3.63 MEUR

Compensation3.63 M EUR

Mr. Julio Triana

(59)

Member of the Management Board, Head of the Consumer Health Division

3.33 MEUR

Compensation3.33 M EUR

API Docs Get API Key

Bayer Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite

30 companies

#	Name	1M	3M	6M	1Y	2Y
1	Farmacias Benavides B	0,69	—	—	—	—
2	Vincerx Pharma Supplier	0,94	-0,84	-0,89	-0,74	—
3	Teixeira Duarte Supplier	0,75	-0,82	-0,91	-0,87	—
4	PT Surya Citra Media Supplier	-0,12	—	—	—	—
5	S4 Capital Supplier	0,56	-0,78	-0,90	-0,79	-0,62

API Docs Get API Key

Bayer Research

Soon

Deep-dive analyses, investment theses, and proprietary research — curated by Eulerpool.

Research reports are coming soon

We're building institutional-grade equity research for Bayer and thousands of other companies.

Most common questions regarding Bayer

The business model of Bayer AG is focused on the development, manufacturing, and sale of healthcare and agricultural products. As a global pharmaceutical and life sciences company, Bayer AG operates in various sectors such as Pharmaceuticals, Consumer Health, Crop Science, and Animal Health. With its innovative research and development, Bayer AG aims to improve people's lives through its products and solutions. By maintaining a diverse portfolio, strong market presence, and strategic partnerships, the company seeks to address global challenges and contribute to a sustainable future in the fields of healthcare and agriculture.

The Bayer AG is a German company that operates in various business sectors. The company is active in the chemical and pharmaceutical industry and offers a wide range of products and services. Pharma and Health One of Bayer's most well-known business sectors is pharma and health. The company produces a variety of medications used for treating diseases such as diabetes, cancer, cardiovascular diseases, and many more. The most well-known medications include the pain reliever Aspirin, the contraceptive Yaz, and the cancer medication Nexavar. Crop Science Another important business sector of Bayer is Crop Science. Bayer produces seeds and plant protection products for the agribusiness sector. The company offers a wide range of products for the cultivation of crops such as grains, vegetables, and fruits. The company also supports farmers in the efficient use of water and energy for sustainable agriculture. Bayer Crop Science is a key player in the global agricultural landscape. Consumer Health Bayer also has a Consumer Health business sector that offers a variety of products for health and personal care. The company produces medications for minor illnesses and diseases such as cold and flu, as well as self-care products such as pain ointments, antiseptics, skin creams, and vitamins. The most well-known products include Coppertone sunscreen and the pain reliever Aleve. Animal Health Bayer also utilizes its expertise in animal health by producing medications and services. This business sector focuses on the health and well-being of livestock and pets. The company has an extensive range of products for the treatment and prevention of disease-related risks in pets as well as livestock. Bayer also has various business sectors focusing on the production of chemicals, materials, and technologies for the production of plastics, paints, adhesives, high-tech products, and more. Overall, Bayer AG's business model is oriented towards strong diversification to minimize risks and seize opportunities in various markets. With a wide range of products and a strong presence in different regions, Bayer continuously generates a high volume of revenue through its strong research and development and is an important company for the German economy.

API Docs Get API Key

Fair ValuePRO

39.17 EUR

Over-/UndervaluationPRO

34.0% undervalued

Expected Return

11.31 %

Sector

Health

Industry

Pharmaceuticals

Number of shares

982,420,000

Employees

99,841

Revenue per Employee

466,802.22 EUR

Revenue growth Ø5 years

2.4 %

EBIT growth Ø5 years

—

Net Income growth Ø5 years

-24.63 %

Website bayer.de

Country

Germany 🇩🇪

Currency

EUR

Initial public offering

Nov 28, 1997

ISIN

DE000BAY0017

Cusip

D0712D163

Sedol

5069211

Market capitalization

45.18 B EURLarge Cap

52-Week Range

41.76–49.32EUR

Bayer Directors Dealings

Quality Investing

Details

1 / 10

Sales growth (10Y) > 5%

Revenue growth (3Y) > 5 %

EBIT growth (10Y) > 5%

EBIT growth (3Y) > 5 %

Net debt < 4x EBIT

Profitable since 10Y+

EBIT Drawdown (10Y) < 50%

Return on Equity (ROE) > 15%

ROCE > 15%

Return Expectation > 10%

PEG

-3.39

P/E ratio

-16.57

P/Ee 2025

8.97

P/Ee 2026

8.81

P/Ee 2027

8.09

P/Ee 2028

7.29

P/Ee 2029

6.9

P/S

0.91

P/Se

0.91

EV/EBIT

19.94

P/B Ratio

ROE (Return on Equity)

ROA (Return on Assets)

ROCE (Return on Capital Employed)

ROIC (Return on Invested Capital)

PROUnlock all valuation metrics

Gross Margin

54.36 %

EBIT Margin

8.57 %

Net Margin

-5.48 %

EPS (Earnings Per Share)

-2.6 EUR

Net Debt / EBIT

8.64

Debt/Equity

Dividend

0.11 EUR

Dividend yield

0.26 %

Est. Dividend Yield

11.67 %

Payout Ratio

115.85 %

Dividend growth Ø5Y

-44.01 %

Dividend payments per year

Dividend paid since

21 years+

Dividend not reduced since

1 year

Dividend increased since

0 years

Dividend withholding tax

26.38 %

Last updated Mar 4, 2026, 8:39 AM

Bayer Peer Group

MPH Health Care AG

Merck KGaA

Dermapharm Holding SEPRO

PharmaSGP Holding SEPRO

Bayer Ticker

BERLIN · BAYN.BEDÜSSELDORF · BAYN.DUFRANKFURT · BAYN.FHAMBURG · BAYN.HMLONDON · 0P6S.LMILAN · 1BAYN.MIMUNICH · BAYN.MUNASDAQ · BAYZFSIX · BAYN.SWSTUTTGART · BAYN.SGVIENNA · BAYN.VIWARSAW · BAY.WAWSE · BAY.WAXETRA · BAYN.DE

Bayer FIGI

BAYN:GR · BBG000BBWDG1BAYN:GF · BBG000BBWDT7BAYN:GD · BBG000BBWF12BAYN:GY · BBG000BBWF85BAYN:GS · BBG000BBWG29BAYN:GM · BBG000BBWH90BAYN:GB · BBG000BBWJ50BAYN:GI · BBG000BBWK02BAYN:GH · BBG000BBWKS2BAYN:SW · BBG000BBWS96BAYN:SE · BBG000BBWT49BAYZF:US · BBG000BX8VK5BAYZF:PQ · BBG000BX91W7BAYZF:UV · BBG000BX92S0BAYND:IX · BBG000DHR6B2BAYCHF:EU · BBG000GDBC68BAYCHF:EO · BBG000GDBCS4BAYCHF:E1 · BBG000GDCV38BAYCHF:XT · BBG000GDCVR2BAYCHF:XW · BBG000GDCWR01BAYN:IM · BBG000GWH1F4BAY:IC · BBG000GWH2K61BAYN:IF · BBG000GWJ509BAY:EO · BBG000J6SMS6BAY:XH · BBG000J6SQ25BAY:XC · BBG000J6SQQ9BAY:XF · BBG000J6SR87BAY:XE · BBG000J6SS94BAY:XJ · BBG000J6SSM9BAY:XL · BBG000J6STJ1BAY:XG · BBG000J6SVX0BAY:XO · BBG000J6SW77BAY:XS · BBG000J6V0V6BAY:XA · BBG000J6V2L3BAY:E1 · BBG000J6V3L1BAY:XT · BBG000J6V3V0BAY:XW · BBG000J6V4C9BAY:EU · BBG000J6V5S9BAYGBX:EU · BBG000JK55G0BAYGBX:EO · BBG000JK55S7BAYGBX:XH · BBG000JK57M9BAYGBX:XC · BBG000JK58J1BAYGBX:XF · BBG000JK59K7BAYGBX:XE · BBG000JK5CK0BAYGBX:XJ · BBG000JK5DC7BAYGBX:XL · BBG000JK5DZ2BAYGBX:XG · BBG000JK5G85BAYGBX:XO · BBG000JK5H56BAYGBX:XS · BBG000JK5L57BAYGBX:XA · BBG000JK5LF6BAYGBX:E1 · BBG000JK5MJ0BAYGBX:XT · BBG000JK5N71BAYGBX:XW · BBG000JK5NP1BAYGBP:EO · BBG000JLW0L3BAYGBP:XH · BBG000JLW319BAYGBP:XC · BBG000JLW3G3BAYGBP:XE · BBG000JLW4C5BAYGBP:XJ · BBG000JLW4K6BAYGBP:XG · BBG000JLW6D9BAYGBP:XO · BBG000JLW6L0BAYGBP:XA · BBG000JLW8Y2BAYGBP:E1 · BBG000JLW9D3BAYGBP:XT · BBG000JLW9Q9BAYGBP:XW · BBG000JLXD43BAYUSD:EU · BBG000K1MJ17BAYUSD:EO · BBG000K1MJS8BAYUSD:E1 · BBG000K1MXZ9BAYUSD:XT · BBG000K1NZN6BAYUSD:XW · BBG000K1Q265BAYAUD:EO · BBG000L4NFC5BAYAUD:E1 · BBG000L4PXS7BAYAUD:XT · BBG000L4PYB3BAYAUD:XW · BBG000L4PZ48BAYAUD:EU · BBG000L4PZN7BAYNOK:EO · BBG000N2L6B0BAYNOK:E1 · BBG000N2MJ12BAYNOK:XT · BBG000N2MJ76BAYNOK:XW · BBG000N2MJP6BAYNOK:EU · BBG000N2ML17BAYND:TQ · BBG000N3MSS1BAYND:BQ · BBG000NZNYK4BAYND:EB · BBG000NZXJ624BAYN:TE · BBG000R8K526BAYCAD:EO · BBG000RNX1Z2BAYCAD:E1 · BBG000RNX7H9BAYCAD:XT · BBG000RNX8M1BAYCAD:XW · BBG000RNX8R6BAYCAD:EU · BBG000RNX9S3BAYN:TH · BBG000TJ1L08BAYEGP:EO · BBG001HTWWQ1BAYEGP:XE · BBG001HTWWY2BAYEGP:E1 · BBG001HTWX89BAYEGP:XT · BBG001HTWX98BAYEGP:XW · BBG001HTWXB5BAYEGP:EU · BBG001HTWXD3BAYND:S1 · BBG001MBWCD2BAYER:HB · BBG002F046D60P6S:LO · BBG0039C2QH9BAYCHF:XV · BBG00591BYV5BAY:XV · BBG00591KM69BAYGBX:XV · BBG00591MGM2BAYGBP:XV · BBG00591MPC3BAYAUD:XV · BBG00591R0X0BAYNOK:XV · BBG00591SBP4BAYCAD:XV · BBG00591X170BAYEGP:XV · BBG00591Z597BAYND:QX · BBG005HKZND2BAYNN:MM · BBG005PTPF88BAYNN:MF · BBG005PTPF97BAYRUB:EO · BBG0066JDZG9BAYRUB:XH · BBG0066JDZK4BAYRUB:XF · BBG0066JDZM2BAYRUB:XE · BBG0066JDZP9BAYRUB:XJ · BBG0066JDZQ8BAYRUB:XL · BBG0066JDZR7BAYRUB:XG · BBG0066JDZS6BAYRUB:XO · BBG0066JDZT5BAYRUB:XS · BBG0066JDZY9BAYRUB:XA · BBG0066JDZZ8BAYRUB:E1 · BBG0066JF001BAYRUB:XT · BBG0066JF010BAYRUB:XW · BBG0066JF029BAYRUB:XU · BBG0066JF038BAYRUB:XV · BBG0066JF056BAYRUB:EU · BBG0066JF0W6BAYN:BW · BBG006M6Y3H6BAYPLN:EO · BBG006N9MLX4BAYPLN:XH · BBG006N9MM08BAYPLN:XF · BBG006N9MM26BAYPLN:XE · BBG006N9MM44BAYPLN:XJ · BBG006N9MM53BAYPLN:XL · BBG006N9MM62BAYPLN:XG · BBG006N9MM71BAYPLN:XO · BBG006N9MM80BAYPLN:XS · BBG006N9MMD4BAYPLN:XA · BBG006N9MMF2BAYPLN:E1 · BBG006N9MMG1BAYPLN:XT · BBG006N9MMH0BAYPLN:XW · BBG006N9MMJ8BAYPLN:XU · BBG006N9MMK6BAYPLN:XV · BBG006N9MMM4BAYPLN:EU · BBG006N9MMT7BAYND:B3 · BBG006T6K2G7BAYND:L3 · BBG006T9VBW1BAYN:QT · BBG0077H5593BAYND:PO · BBG008GZCHY9BAYNEUR:SW · BBG008P7G3S5BAYNEUR:SE · BBG008P7G3V1BAYE:B3 · BBG00CX7Z1J0BAYE:PO · BBG00CX81CV7BAYE:L3 · BBG00CX88WD6BAYN:GZ · BBG00FGWTXC1BAYN:RO · BBG00GWY7PX5BAYN:RE · BBG00GWY7PY4BAYNZ:PO · BBG00GXZSPL1BAYNZ:L3 · BBG00GXZSRK8BAYNZ:B3 · BBG00GXZSSD4BAYNZ:EB · BBG00GY0DGG9BAYNZ:IX · BBG00GY0DGW1BAYN:AV · BBG00GY18HF2BAY:XM · BBG00J9VPKC5BAYCHF:XX · BBG00JN78LR3BAY:XX · BBG00JN7H801BAYGBX:XX · BBG00JN7K3S8BAYGBP:XX · BBG00JN7KBJ0BAYUSD:XX · BBG00JN7LCK5BAYAUD:XX · BBG00JN7NNY4BAYNOK:XX · BBG00JN7PZR3BAYCAD:XX · BBG00JN7TNR6BAYEGP:XX · BBG00JN7WTB6BAYRUB:XX · BBG00JN869R0BAYPLN:XX · BBG00JN871Y8BAYNN:MU · BBG00JX0PB36BAYHUF:EO · BBG00KDNYFP2BAYHUF:XH · BBG00KDNYFS9BAYHUF:XF · BBG00KDNYFV5BAYHUF:XE · BBG00KDNYFX3BAYHUF:XJ · BBG00KDNYFY2BAYHUF:XL · BBG00KDNYFZ1BAYHUF:XG · BBG00KDNYG07BAYHUF:XO · BBG00KDNYG16BAYHUF:XS · BBG00KDNYG52BAYHUF:XA · BBG00KDNYG61BAYHUF:E1 · BBG00KDNYG70BAYHUF:XT · BBG00KDNYG89BAYHUF:XW · BBG00KDNYG98BAYHUF:XU · BBG00KDNYGB5BAYHUF:XV · BBG00KDNYGC4BAYHUF:XM · BBG00KDNYGD3BAYHUF:XQ · BBG00KDNYGG0BAYHUF:XX · BBG00KDNYGH9BAYHUF:XZ · BBG00KDNYGJ7BAYHUF:EU · BBG00KDNYGL4BAYNEUR:T2 · BBG00MZYZRL7BAYND:QE · BBG00NL2M9Y0BAYND:T1 · BBG00NLK3LK9BAYND:I2 · BBG00NQB52K4BAYNEUR:WT · BBG00NR8NZQ1BAYRON:XS · BBG00PPZ6MM0BAYRON:XH · BBG00PPZ6MQ6BAYRON:XF · BBG00PPZ6MS4BAYRON:XD · BBG00PPZ6MT3BAYRON:XE · BBG00PPZ6MV0BAYRON:XJ · BBG00PPZ6MW9BAYRON:XL · BBG00PPZ6MX8BAYRON:XG · BBG00PPZ6MY7BAYRON:XO · BBG00PPZ6MZ6BAYRON:XN · BBG00PPZ6N02BAYRON:XA · BBG00PPZ6N39BAYRON:XT · BBG00PPZ6N57BAYRON:XW · BBG00PPZ6N66BAYRON:XU · BBG00PPZ6N75BAYRON:XV · BBG00PPZ6N84BAYRON:XM · BBG00PPZ6N93BAYRON:EU · BBG00PPZ6NG5BAYERT:PO · BBG00XTVRQJ0BAYERT:L3 · BBG00XTVRRV4BAYERT:B3 · BBG00XTVRS33BAYERT:L1 · BBG00Y7BFVT7BAYND:L1 · BBG00Y7BFW06BAYNZ:L1 · BBG00Y7BFW51BAYND:S4 · BBG00YJ84L06BAYN:LA · BBG018H7GL85BAYN:LU · BBG018J13NR5BAY:PW · BBG01H6YCKZ4

All fundamentals about Bayer

Our stock analysis for Bayer Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bayer Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Bayer Directors Dealings→

Bayer Stocks→

Bayer Market capitalization→

Bayer Debt→

Bayer Liabilities→

Bayer Equity→